Fineline Cube

Follow:
14435 Articles
CompanyDrug

Avistone’s Vebreltinib Wins NMPA Approval for MET-Amplified NSCLC

Hengrui Pharmaceuticals Gains NMPA Approval for Aisuda in Severe Alopecia Areata
CompanyDrug

Hengrui Pharmaceuticals Gains NMPA Approval for Aisuda in Severe Alopecia Areata

MicroPort NeuroTech's NUMEN Nest Gains FDA Marketing Approval
CompanyMedical Device

MicroPort NeuroTech’s NUMEN Nest Gains FDA Marketing Approval

BMS Secures FDA Approval for Updated Labels of Breyanzi and Abecma
CompanyDrug

BMS Secures FDA Approval for Updated Labels of Breyanzi and Abecma

GenScript Receives $213.8M Payment from LaNova for PD-1 Antibody License
CompanyDeals

GenScript Receives $213.8M Payment from LaNova for PD-1 Antibody License

UCB's Fenfluramine Shows Positive Results in Phase III GEMZ Study for CDKL5 Deficiency Disorder
CompanyDrug

UCB’s Fenfluramine Shows Positive Results in Phase III GEMZ Study for CDKL5 Deficiency Disorder

Sunshine Lake Pharma Lists on HKEX via Introduction Method
CompanyDeals

Sunshine Lake Pharma Lists on HKEX via Introduction Method

MGI Tech Partners with Italy's Negedia to Advance Genomic Sequencing and Spatial Transcriptomics
CompanyDeals

MGI Tech Partners with Italy’s Negedia to Advance Genomic Sequencing and Spatial Transcriptomics

China Proposes Healthcare Security Law to Strengthen Medical Insurance System
Policy / Regulatory

China Proposes Healthcare Security Law to Strengthen Medical Insurance System

QuantumPharm and Pfizer Expand Collaboration on Advanced Molecular Simulation Platform
CompanyDeals

QuantumPharm and Pfizer Expand Collaboration on Advanced Molecular Simulation Platform

BlissBio Inc. Files for Hong Kong IPO to Advance Oncology-Focused ADC Pipeline
CompanyDeals

BlissBio Inc. Files for Hong Kong IPO to Advance Oncology-Focused ADC Pipeline

FDA Removes REMS Requirements for BCMA- and CD19-Targeted CAR-T Therapies
Policy / Regulatory

FDA Removes REMS Requirements for BCMA- and CD19-Targeted CAR-T Therapies